FDA Approval Summary: Tisagenlecleucel for Treatment of...

  • Main
  • 2018 / 10
  • FDA Approval Summary: Tisagenlecleucel for Treatment of...

FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

O'Leary, Maura C., Lu, Xiaobin, Huang, Ying, Lin, Xue, Mahmood, Iftekhar, Przepiorka, Donna, Gavin, Denise, Lee, Shiowjen, Liu, Ke, George, Bindu, Bryan, Wilson, Theoret, Marc R., Pazdur, Richard
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-18-2035
Date:
October, 2018
File:
PDF, 470 KB
english, 2018
Conversion to is in progress
Conversion to is failed